Cardinal Health (CAH) Beat the Market in 2025 with Solid Healthcare Momentum

Cardinal Health, Inc. (NYSE:CAH) is one of the Best Dividend Stocks of 2025.

Cardinal Health (CAH) Beat the Market in 2025 with Solid Healthcare Momentum

A senior physician in a modern healthcare institution administering medication to a patient.

Cardinal Health, Inc. (NYSE:CAH) has surged by nearly 39% since the start of 2025. The company remains focused on strengthening the growth and stability of its Pharmaceutical and Specialty Solutions segment by expanding its presence in specialty care, advancing high-growth areas, and continuing the execution of its GMPD Improvement Plan.

Cardinal Health, Inc. (NYSE:CAH) has also reaffirmed its commitment to investing in Biopharma Solutions. Its Specialty Networks are broadening the reach of their PPS Analytics and SoNaR data platforms, which were initially developed for urology. These platforms are now being extended into oncology, gastroenterology, and rheumatology to better support manufacturing partners and healthcare providers, including physicians connected through Cardinal Health’s MSO platforms.

On May 6, Cardinal Health, Inc. (NYSE:CAH) declared a 1% hike in its quarterly dividend to $0.5107 per share. Through this increase, the company stretched its dividend growth streak to 39 years. The stock offers a dividend yield of 1.23%, as of June 26.

While we acknowledge the potential of CAH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Dividend Stocks for a Bear Market and 10 Best Dividend Stocks to Buy for Dependable Dividend Growth.

Disclosure. None.